Angulo Gonzalez David

Average Profitability
18.39%
Insider Buys Quantity
12
Insider Buys Sum
$310,010.30
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Angulo Gonzalez David

According to the SEC Form 4 filings, Angulo Gonzalez David, being in a position of

  1. Chief Executive Officer at SCYNEXIS, Inc.,
    оver the last 12 months, has bought 20000 shares for $27,400, and sold 0 shares,
    over all time since 2015-09-15, has bought 184130 shares for $310,010, and sold 0 shares.

The largest purchase of all time was on 2016-06-30 and amounted to 32150 shares of SCYNEXIS, Inc. for $71,695.

Biography of Angulo Gonzalez David

No biography is available at this moment.

2024-09-12PurchaseSCYNEXIS, Inc.
SCYX
Chief Executive Officer
20,000
0.054%
$1.37$27,400+0.75%
2020-12-21PurchaseSCYNEXIS, Inc.
SCYX
Chief Medical Officer
1,600
0.0152%
$6.25$10,000+18.08%
2018-12-31PurchaseSCYNEXIS, Inc.
SCYX
Chief Medical Officer
24,000
0.0501%
$0.50$11,902+140.66%
2018-09-06PurchaseSCYNEXIS, Inc.
SCYX
Chief Medical Officer
14,000
0.0282%
$1.27$17,780-10.45%
2018-03-29PurchaseSCYNEXIS, Inc.
SCYX
Chief Medical Officer
12,000
0.0363%
$1.36$16,320-5.22%
2018-03-08PurchaseSCYNEXIS, Inc.
SCYX
Chief Medical Officer
43,580
0.1488%
$1.59$69,450-8.63%
2017-08-11PurchaseSCYNEXIS, Inc.
SCYX
Chief Medical Officer
10,000
0.0367%
$1.55$15,500+13.78%
2017-05-12PurchaseSCYNEXIS, Inc.
SCYX
Chief Medical Officer
15,000
0.0585%
$1.70$25,500+6.51%
2016-12-16PurchaseSCYNEXIS, Inc.
SCYX
Chief Medical Officer
4,000
0.0158%
$3.25$13,000-33.23%
2016-06-30PurchaseSCYNEXIS, Inc.
SCYX
Chief Medical Officer
32,150
0.141%
$2.23$71,695+33.87%
2016-06-29PurchaseSCYNEXIS, Inc.
SCYX
Chief Medical Officer
4,800
0.0317%
$2.18$10,464+28.54%
2015-09-15PurchaseSCYNEXIS, Inc.
SCYX
Chief Medical Officer
3,000
0.0217%
$7.00$21,000-38.27%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.